ProShare Advisors LLC

Position in OGN — Organon & Co.

CIK 1357955 BETHESDA, MD

Position in OGN

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$423,355

-$1,243,882 QoQ

Shares Held

31,267

-67.4% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#198

of 626 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $1,455,266,466 across 11 Drug Manufacturers - General names. OGN ranks #10 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	2,829,082	$357,426,219
2	JNJ	Johnson & Johnson	1,198,505	$304,384,314
3	ABBV	AbbVie Inc.	1,073,381	$270,105,594
4	AMGN	Amgen Inc	697,030	$252,408,503
5	LLY	ELI LILLY & Co	129,204	$154,971,166
6	MRK	Merck & Co., Inc.	517,507	$66,499,649
7	PFE	Pfizer Inc	906,089	$21,818,623
8	BMY	Bristol Myers Squibb Co	335,197	$19,314,051

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$423,355	31,267	-67.4%	Shares	Sole	2026-08-11
2023-09-30	$1,667,237	96,039	+137.0%	Shares	Sole	2023-11-13
2023-06-30	$843,200	40,519	+3.1%	Shares	Sole	2023-08-10
2023-03-31	$924,147	39,292	-24.6%	Shares	Sole	2023-05-26
2022-12-31	$1,454,566	52,079	-1.2%	Shares	Sole	2023-02-02
2022-09-30	$1,232,852	52,686	-5.5%	Shares	Sole	2022-11-07
2022-06-30	$1,882,271	55,771	-22.5%	Shares	Sole	2022-08-01
2022-03-31	$2,513,492	71,958	-6.6%	Shares	Sole	2022-05-10
2021-12-31	$2,345,868	77,040	+40.1%	Shares	Sole	2022-02-08
2021-09-30	$1,803,089	54,989	-41.6%	Shares	Sole	2021-11-12
2021-06-30	$2,850,492	94,200	—	Shares	Sole	2021-08-13
No filing history on record for this holder in this stock.